Loading...

Ibere Pharmaceuticals

IBER•NYSE
Financial Services
Shell Companies
$10.18
$-0.02(-0.20%)

Ibere Pharmaceuticals (IBER) Stock Overview

Explore Ibere Pharmaceuticals’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.7/100

Key Financials

Market Cap175.6M
P/E Ratio96.92
EPS (TTM)$0.59
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$11.97

IBER Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ibere Pharmaceuticals (IBER) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $11.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 96.92 and a market capitalization of 175.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for IBERStats details for IBER are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for IBERAnalyst Recommendations details for IBER are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

CEO

Osagie O. Imasogie

Headquarters

2005 Market Street, Philadelphia, PA

Founded

1970

Frequently Asked Questions

;